A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...
“We’re pleased to report that EBC-46 performed extremely well in preclinical experiments as part of a ‘kick and kill’ therapeutic,” said study senior author Paul Wender, the Bergstrom Professor of ...